Cargando…

Immunogenic Evaluation of Ribosomal P-Protein Antigen P0, P1, and P2 and Pentameric Protein Complex P0-(P1-P2)(2) of Plasmodium falciparum in a Mouse Model

Malaria remains one the most infectious and destructive protozoan diseases worldwide. Plasmodium falciparum, a protozoan parasite with a complex life cycle and high genetic variability responsible for the difficulties in vaccine development, is implicated in most malaria-related deaths. In the cours...

Descripción completa

Detalles Bibliográficos
Autores principales: Szuster-Ciesielska, Agnieszka, Wawiórka, Leszek, Krokowski, Dawid, Grankowski, Nikodem, Jarosz, Łukasz, Lisiecka, Urszula, Tchórzewski, Marek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6757288/
https://www.ncbi.nlm.nih.gov/pubmed/31612155
http://dx.doi.org/10.1155/2019/9264217
_version_ 1783453550977744896
author Szuster-Ciesielska, Agnieszka
Wawiórka, Leszek
Krokowski, Dawid
Grankowski, Nikodem
Jarosz, Łukasz
Lisiecka, Urszula
Tchórzewski, Marek
author_facet Szuster-Ciesielska, Agnieszka
Wawiórka, Leszek
Krokowski, Dawid
Grankowski, Nikodem
Jarosz, Łukasz
Lisiecka, Urszula
Tchórzewski, Marek
author_sort Szuster-Ciesielska, Agnieszka
collection PubMed
description Malaria remains one the most infectious and destructive protozoan diseases worldwide. Plasmodium falciparum, a protozoan parasite with a complex life cycle and high genetic variability responsible for the difficulties in vaccine development, is implicated in most malaria-related deaths. In the course of study, we prepared a set of antigens based on P-proteins from P. falciparum and determined their immunogenicity in an in vivo assay on a mouse model. The pentameric complex P0-(P1-P2)(2) was prepared along with individual P1, P2, and P0 antigens. We determined the level of cellular- and humoral-type immunological response followed by development of specific immunological memory. We have shown that the number of Tc cells increased significantly after the first immunization with P2 and after the second immunization with P1 and P0-(P1-P2)(2), which highly correlated with the number of Th1 cells. P0 appeared as a poor inducer of cellular response. After the third boost with P1, P2, or P0-(P1-P2)(2), the initially high cellular response dropped to the control level accompanied by elevation of the number of activated Treg cells and a high level of suppressive TGF-β. Subsequently, the humoral response against the examined antigens was activated. Although the titers of specific IgG were increasing during the course of immunization for all antigens used, P2 and P0-(P1-P2)(2) were found to be significantly stronger than P1 and P0. A positive correlation between the Th2 cell abundance and the level of IL-10 was observed exclusively after immunization with P0-(P1-P2)(2). An in vitro exposure of spleen lymphocytes from the immunized mice especially to the P1, P2, and P0-(P1-P2)(2) protein caused 2-3-fold higher cell proliferation than that in the case of lymphocytes from the nonimmunized animals, suggesting development of immune memory. Our results demonstrate for the first time that the native-like P-protein pentameric complex represents much stronger immune potential than individual P-antigens.
format Online
Article
Text
id pubmed-6757288
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-67572882019-10-14 Immunogenic Evaluation of Ribosomal P-Protein Antigen P0, P1, and P2 and Pentameric Protein Complex P0-(P1-P2)(2) of Plasmodium falciparum in a Mouse Model Szuster-Ciesielska, Agnieszka Wawiórka, Leszek Krokowski, Dawid Grankowski, Nikodem Jarosz, Łukasz Lisiecka, Urszula Tchórzewski, Marek J Immunol Res Research Article Malaria remains one the most infectious and destructive protozoan diseases worldwide. Plasmodium falciparum, a protozoan parasite with a complex life cycle and high genetic variability responsible for the difficulties in vaccine development, is implicated in most malaria-related deaths. In the course of study, we prepared a set of antigens based on P-proteins from P. falciparum and determined their immunogenicity in an in vivo assay on a mouse model. The pentameric complex P0-(P1-P2)(2) was prepared along with individual P1, P2, and P0 antigens. We determined the level of cellular- and humoral-type immunological response followed by development of specific immunological memory. We have shown that the number of Tc cells increased significantly after the first immunization with P2 and after the second immunization with P1 and P0-(P1-P2)(2), which highly correlated with the number of Th1 cells. P0 appeared as a poor inducer of cellular response. After the third boost with P1, P2, or P0-(P1-P2)(2), the initially high cellular response dropped to the control level accompanied by elevation of the number of activated Treg cells and a high level of suppressive TGF-β. Subsequently, the humoral response against the examined antigens was activated. Although the titers of specific IgG were increasing during the course of immunization for all antigens used, P2 and P0-(P1-P2)(2) were found to be significantly stronger than P1 and P0. A positive correlation between the Th2 cell abundance and the level of IL-10 was observed exclusively after immunization with P0-(P1-P2)(2). An in vitro exposure of spleen lymphocytes from the immunized mice especially to the P1, P2, and P0-(P1-P2)(2) protein caused 2-3-fold higher cell proliferation than that in the case of lymphocytes from the nonimmunized animals, suggesting development of immune memory. Our results demonstrate for the first time that the native-like P-protein pentameric complex represents much stronger immune potential than individual P-antigens. Hindawi 2019-09-12 /pmc/articles/PMC6757288/ /pubmed/31612155 http://dx.doi.org/10.1155/2019/9264217 Text en Copyright © 2019 Agnieszka Szuster-Ciesielska et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Szuster-Ciesielska, Agnieszka
Wawiórka, Leszek
Krokowski, Dawid
Grankowski, Nikodem
Jarosz, Łukasz
Lisiecka, Urszula
Tchórzewski, Marek
Immunogenic Evaluation of Ribosomal P-Protein Antigen P0, P1, and P2 and Pentameric Protein Complex P0-(P1-P2)(2) of Plasmodium falciparum in a Mouse Model
title Immunogenic Evaluation of Ribosomal P-Protein Antigen P0, P1, and P2 and Pentameric Protein Complex P0-(P1-P2)(2) of Plasmodium falciparum in a Mouse Model
title_full Immunogenic Evaluation of Ribosomal P-Protein Antigen P0, P1, and P2 and Pentameric Protein Complex P0-(P1-P2)(2) of Plasmodium falciparum in a Mouse Model
title_fullStr Immunogenic Evaluation of Ribosomal P-Protein Antigen P0, P1, and P2 and Pentameric Protein Complex P0-(P1-P2)(2) of Plasmodium falciparum in a Mouse Model
title_full_unstemmed Immunogenic Evaluation of Ribosomal P-Protein Antigen P0, P1, and P2 and Pentameric Protein Complex P0-(P1-P2)(2) of Plasmodium falciparum in a Mouse Model
title_short Immunogenic Evaluation of Ribosomal P-Protein Antigen P0, P1, and P2 and Pentameric Protein Complex P0-(P1-P2)(2) of Plasmodium falciparum in a Mouse Model
title_sort immunogenic evaluation of ribosomal p-protein antigen p0, p1, and p2 and pentameric protein complex p0-(p1-p2)(2) of plasmodium falciparum in a mouse model
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6757288/
https://www.ncbi.nlm.nih.gov/pubmed/31612155
http://dx.doi.org/10.1155/2019/9264217
work_keys_str_mv AT szusterciesielskaagnieszka immunogenicevaluationofribosomalpproteinantigenp0p1andp2andpentamericproteincomplexp0p1p22ofplasmodiumfalciparuminamousemodel
AT wawiorkaleszek immunogenicevaluationofribosomalpproteinantigenp0p1andp2andpentamericproteincomplexp0p1p22ofplasmodiumfalciparuminamousemodel
AT krokowskidawid immunogenicevaluationofribosomalpproteinantigenp0p1andp2andpentamericproteincomplexp0p1p22ofplasmodiumfalciparuminamousemodel
AT grankowskinikodem immunogenicevaluationofribosomalpproteinantigenp0p1andp2andpentamericproteincomplexp0p1p22ofplasmodiumfalciparuminamousemodel
AT jaroszłukasz immunogenicevaluationofribosomalpproteinantigenp0p1andp2andpentamericproteincomplexp0p1p22ofplasmodiumfalciparuminamousemodel
AT lisieckaurszula immunogenicevaluationofribosomalpproteinantigenp0p1andp2andpentamericproteincomplexp0p1p22ofplasmodiumfalciparuminamousemodel
AT tchorzewskimarek immunogenicevaluationofribosomalpproteinantigenp0p1andp2andpentamericproteincomplexp0p1p22ofplasmodiumfalciparuminamousemodel